Owlet, Inc.

NYSE:OWLT

Medical - Devices

Healthcare
$3.67 +9.76%

+$0.46 today

Market cap
$107.24M
Beta
1.86
P/E (TTM)
-0.4
EPS (TTM)
-$12.67
52W Low $4.19High $16.94

Volume 0.64M

Average 0.24M

OWLT Net Receivables

Amounts owed to the company by customers and others, net of allowances for uncollectible accounts.

Owlet, Inc.NYSE: OWLT

Net Receivables · Q1 FY2026 · quarter ended Mar 2026

Net receivables rises 20.2% from a year ago

Net receivables stood at $19.86M at the end of Q1 FY2026, up 20.2% from a year earlier and down 13.3% from the prior quarter. Over 3 fiscal years it compounded at +12.8% a year.

Context

  • Net receivables amounted to 22.9% of total assets at the end of Q1 FY2026, down 9.3 pp from a year earlier.
  • Net receivables increased in 1 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether net receivables keeps rising in the next quarterly balance sheet after a +20.2% change from a year earlier.

Sources:Balance SheetText generated from reported figures; not investment advice.

Latest quarterMar 2026
$19.86M-13.3% QoQ
Last fiscal yearDec 2025
$22.9M+88.7% YoY
Year agoMar 2025
$16.53M+20.2% since
Net Receivables past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+20.2%——
1 year+88.7%——
3-year CAGR+12.8%——
5-year CAGR——
10-year CAGR——

Net Receivables history

USD · from the balance sheet

Latest · FY2025
22.9M USD
Year-over-year change
+88.7%
4-year CAGR
+21.6%

Net Receivables vs competitors

How OWLT compares with its peers on the latest reported figures

  • OWLT's Mar 2026 net receivables of $19.86M is the 2nd highest of the 10 companies compared; the peer median is $689K.
  • Its year-over-year change of +20.2% is the 4th highest of 8, against a peer median of +17.2%.
  • Net receivables amounts to 22.9% of total assets for OWLT, versus a peer median of 2.0%.
OWLT Competitors Peer median
Net Receivables for OWLT and competitors
Company Period Latest balance YoY 3-year CAGR% of assets
ANIKAnika Therapeutics, Inc.Mar 2026$25.77M +17.2%-11.9%14.4%
OWLTOwlet, Inc.Mar 2026$19.86M +20.2%+12.8%22.9%
RPIDRapid Micro Biosystems, Inc.Mar 2026$6.49M +43.3%-15.7%10.4%
LNSRLENSAR, Inc.Mar 2026$5.18M -28.4%+0.7%7.8%
MXCTMaxCyte, Inc.Mar 2026$4.25M -23.1%-32.1%2.2%
LUCDLucid Diagnostics Inc.Mar 2026$689K +1029.5%+235.7%2.0%
AVRAnteris Technologies Global Corp.Mar 2026$231K +22.2%-72.4%0.1%
CRDFCardiff Oncology, Inc.Mar 2026$191K -52.8%-38.2%0.4%
CRBPCorbus Pharmaceuticals Holdings, Inc.Mar 2026$0 ——0.0%
ELTXElicio Therapeutics, Inc.Mar 2026$0 ——0.0%
Peer median (excluding OWLT) $689K+17.2%-15.7%2.0%

Competitors are the stored peer set for OWLT. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Balance Sheet

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Cash & Equivalents95.05M11.23M16.56M20.25M35.5M
Short-term Investments00000
Net Receivables10.47M15.96M13.97M12.14M22.9M
Inventory17.98M18.52M6.49M10.52M15.3M
Other Current Assets001386K8.2M
Total Current Assets135.82M51.26M39.94M46.11M81.9M
Property, Plant & Equipment (Net)1.87M3.37M1.31M240K400K
Goodwill00000
Intangible Assets1.7M2.28M2.21M975K1.4M
Long-term Investments00000
Tax Assets00000
Other Non-current Assets666K1.2M655K2.19M1.9M
Total Non-current Assets4.23M6.84M4.18M3.4M3.7M
Total Assets140.05M58.1M44.12M49.52M85.6M
Account Payables27.77M30.43M13.68M11.28M12M
Short-term Debt8.53M15.04M15.19M7.37M10.57M
Tax Payables00000
Deferred Revenue1.06M0002.3M
Other Current Liabilities08.62M4.09M2.31M(94K)
Total Current Liabilities69.09M66.6M45.09M36.43M44.2M
Long-term Debt7.99M004.33M2.46M
Deferred Tax Liabilities00000
Deferred Revenue (Non-current)00000
Other Non-current Liabilities7.77M975K28.69M29.82M3.47M
Total Non-current Liabilities15.77M2.14M28.71M34.23M5.93M
Total Liabilities84.86M68.74M73.8M70.66M50.2M
Common Stock11K1K1K2K3K
Retained Earnings(143.42M)(222.76M)(255.66M)(268.2M)(307.87M)
Accumulated OCI00000
Other Stockholders Equity00000
Minority Interest00000
Total Equity55.19M(10.64M)(29.68M)(21.15M)35.4M
Total Debt16.53M18.31M16.39M11.87M13.03M
Net Debt(78.53M)7.07M(172K)(8.38M)(22.47M)

Owlet, Inc.

NYSE:OWLT

Intrinsic Alpha fair value

Locked

Current Price

$3.67

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.